Go to www.sensodetect.se

Nomination Committee appointed

In accordance with the decision by the Annual General Meeting May 12, 2011, the nominating committee shall consist of representatives of the 3 largest shareholders as of 30 June 2011, and Chairman of the Board.
 
For the 2012 AGM, the nominating committee will propose board members and chairman, and fees for directors and auditors.

The following persons have been appointed members of the nominating committee with chairman Leif Smeby as convener:

Sara Nehlstedt
Lars Gunnarson
Ann Lindvall Olsson
 

Under the leadership of chairman, the nomination committee shall prepare proposals for a new board which will be presented and decided on at the AGM on March 7, 2012.

For more information:
Johan Källstrand, CEO SensoDetect AB

Phone: + 46 (0) 736-770088
E-mail:

SensoDetect has developed a method for objective neurophysiological decision support for diagnostics, primarily in psychiatric health care and forensics. The technology underlying SensoDetect’s test instrument, SensoDetect® BERA, is based on brainstem audiometry and is the result of extensive research at Lund University.